Jason Haddock - Jun 17, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Jason Haddock
Stock symbol
CDAKQ
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 04:51 PM
Previous filing
Feb 18, 2022
Next filing
Feb 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Stock Option (Right to Buy) Award $0 +7.5K $0.00 7.5K Jun 17, 2022 Common Stock 7.5K $2.83 Direct F1
transaction CDAKQ Restricted Stock Units Award $0 +1.5K $0.00 1.5K Jun 17, 2022 Common Stock 1.5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.